Century Therapeutics (IPSC) Other Working Capital Changes (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Other Working Capital Changes data on file, last reported at -$786000.0 in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 31.89% year-over-year to -$786000.0 in Q1 2026; TTM through Mar 2026 was -$4.6 million, a 97.6% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 47.93% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$786000.0, up from -$1.4 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for IPSC reached as high as $121.8 million in Q2 2022 and fell as low as -$120.3 million in Q3 2022.
• Historically, Other Working Capital Changes has averaged $479750.0 across 5 years, with a median of -$274000.0 in 2023.
• On a YoY basis, Other Working Capital Changes climbed as much as 52520.0% in 2022 and fell as far as 219.69% in 2022.
• Year by year, Other Working Capital Changes stood at $2.1 million in 2022, then increased by 14.92% to $2.4 million in 2023, then slumped by 132.29% to -$766000.0 in 2024, then slumped by 82.64% to -$1.4 million in 2025, then jumped by 43.82% to -$786000.0 in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$786000.0 in Q1 2026, -$1.4 million in Q4 2025, and -$1.2 million in Q3 2025.